[Icterigenic hepatitis during the treatment with combined isoniazid and rifampicin. Clinical and experimental observations].
D000328:Adult; D000368:Aged; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D006505:Hepatitis / Q000473:pathology; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects*; D007565:Jaundice / Q000139:chemically induced*; D008099:Liver / Q000473:pathology; D008297:Male; D051379:Mice; D008875:Middle Aged; D051381:Rats; D012293:Rifampin / Q000009:adverse effects*
D007538:Isoniazid; D012293:Rifampin
Les hépatites ictérigènes au cours des traitements associant isoniazide et rifampicine. Observations cliniques et expérimentales.